Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
Centro de Diagnóstico Pneumológico de Vila Nova de Gaia, Vila Nova Gaia, Portugal. raquelafduarte@gmail.com
R
R
Duarte
A
A
Carvalho
A
A
Correia
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015331:Cohort Studies; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use*; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008297:Male; D010349:Patient Compliance; D011174:Portugal; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin